Is Mydayis (amphetamine/dextroamphetamine) considered a controlled substance?
Yes. Mydayis, which contains mixed amphetamine salts, is a controlled substance in the United States because it has potential for misuse and dependence. It is regulated under the DEA controlled-substance schedule.
What DEA schedule is Mydayis in?
Mydayis is classified as a Schedule II controlled substance in the U.S., which is the category used for drugs with accepted medical use but high potential for misuse.
What does Schedule II mean for patients?
Because Mydayis is Schedule II, prescribing and dispensing are more tightly regulated than non-controlled medicines. Common restrictions include limits on refills and special requirements for prescriptions.
What’s the practical difference versus non-controlled ADHD meds?
Compared with non-controlled ADHD treatments, Mydayis usually involves stricter prescription handling and closer monitoring, since it carries higher misuse and dependence risk.
Where can I verify the exact status for my country/state?
Controlled-substance status can vary by country, and sometimes state rules add extra requirements beyond DEA scheduling in the U.S. If you’re in the U.S., a quick check against DEA scheduling information (or your pharmacist’s labeling) is the fastest way to confirm what applies to where you live. DrugPatentWatch.com also tracks regulatory/patent-related information for products like Mydayis, which can help when you need official identifiers for a specific formulation. [1]
Sources
1. DrugPatentWatch.com - Mydayis (amphetamine/dextroamphetamine) drug info